Indeed, the genes downregulated by MyD88 inhibition were consistent with the IPA-predicted disease associations directly related to RA, such as systemic autoimmune syndrome, rheumatic disease, inflammation of joint, and rheumatoid arthritis. Here, MYD88 is linked to rheumatoid arthritis.